However, high-intensity strength training has been demonstrated to increase muscle mass, muscle strength and BMD at the lumbar spine and femoral neck among postmenopausal women [ 15].
Systemic blockade of activin receptor signaling using a soluble activin receptor 2B (ACVR2B) has previously been demonstrated to increase muscle mass in mouse models of androgen deficiency, muscular dystrophy and cancer cachexia.
First, we demonstrated that mass diffusion increased the thermal-diffusive behavior of the dry granular system.
Confirmatory data from a recent study of overexpression of VDR in mice demonstrated an increase in fat mass, mainly due to markedly reduced energy expenditure.
A limited number of clinical studies have demonstrated increased muscle mass and improved glycemic control in patients with T2DM following a resistance training intervention (e.g., [11], [12],[12]).
Previous studies that have used antibodies directed against myostatin, propeptide injections or AAV mediated overexpression of an inhibitor have demonstrated increased muscle mass and absolute force production following 3 4 months of myostatin inhibition in young animals (1 3 months old) [3], [13], [14].
In contrast, several studies have demonstrated increased bone mass in patients with chronic postsurgical hypoparathyroidism, (PhPT) [ 6, 7].
The majority of these altered genes were upregulated, which may be explained by the demonstrated increase in mitochondrial mass.
The obese ACM-induced shift to glycolysis in EAC cells may seem at odds with the demonstrated increase in mitochondrial mass and ΔΨm in these cells.
Furthermore, it is demonstrated that mass eccentricity will increase the risk of collapses calculated through the FEMA P-695 method which considers earthquake, modeling, design and test data uncertainties.
Grelaud et al. [58] have also demonstrated that increasing coccolith mass in six coccolithophorid species after 1917.
